| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 133, 2531-2539, Copyright © 1993 by Endocrine Society
ARTICLES |
TG Unterman, JJ Jentel, DT Oehler, RG Lacson and JF Hofert
Department of Medicine, University of Illinois College of Medicine, Chicago.
Circulating levels and hepatic expression of insulin-like growth factor- binding protein-1 (IGFBP-1) are increased in insulin-deficient streptozotocin (STZ)-diabetic rats. Glucocorticoids stimulate and insulin suppresses hepatocellular expression of IGFBP-1 in vitro. We asked whether increased IGFBP-1 expression in STZ-diabetic animals is due to an effect of insulin deficiency per se or whether insulin deficiency represents a permissive state where glucocorticoids may play an important role in the regulation of IGFBP-1 and other circulating peptides involved in the modulation of IGF bioactivity. Intact female Sprague-Dawley-derived rats and rats undergoing bilateral adrenalectomy (ADNX) were injected with STZ (140 mg/kg) or buffer. Corticosterone acetate (50 mg/kg) or vehicle was administered to diabetic and nondiabetic animals immediately after ADNX and 24 h later. All rats were killed 48 h after surgery and/or STZ administration. Serum [125I]IGF-I-binding activity was increased 4-fold (P < 0.01), and Western ligand and immunoblotting demonstrated that levels of IGFBP-1 were high in intact STZ-diabetic animals. ADNX prevented these effects of STZ-diabetes, and corticosterone treatment restored serum IGF- binding activity and IGFBP-1 to intact diabetic levels. Similarly, Northern analysis demonstrated that the abundance of hepatic IGFBP-1 mRNA was increased 6-fold in intact STZ-diabetic animals (P < 0.01), but not in adrenalectomized diabetic animals. Corticosterone treatment restored hepatic IGFBP-1 mRNA to intact diabetic levels, and serum concentrations of corticosterone correlated with the abundance of IGFBP- 1 mRNA (r = 0.475; P < 0.01), indicating that glucocorticoids play an important role in the regulation of expression of IGFBP-1 in insulin- deficient animals. In contrast, neither ADNX nor corticosterone altered the abundance of hepatic IGFBP-1 mRNA levels in nondiabetic animals. This pattern of regulation appeared to be specific; serum levels of immunoreactive IGFBP-2 and -4 tended to rise in adrenalectomized animals, and levels of IGFBP-3 were not affected by either ADNX or corticosterone treatment. Of note, serum levels of IGF-I by RIA were reduced in STZ-diabetic animals compared to control values (168 +/- 16 vs. 587 +/- 55 ng/ml, respectively; P < 0.01), were partially restored toward control values with ADNX (320 +/- 22 ng/ml), and were reduced again by corticosterone treatment (195 +/- 26 ng/ml), indicating that glucocorticoids also contribute to the regulation of IGF-I levels in insulin-deficient animals. The abundance of IGF-I mRNA was reduced in STZ-diabetic animals, and ADNX also partially prevented this effect of diabetes.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
J. Svensson, A. Tivesten, K. Sjogren, O. Isaksson, G. Bergstrom, S. Mohan, J. Molne, J. Isgaard, and C. Ohlsson Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression J. Endocrinol., June 1, 2007; 193(3): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gan, H. Pan, and T. G. Unterman Insulin Response Sequence-Dependent and -Independent Mechanisms Mediate Effects of Insulin on Glucocorticoid-Stimulated Insulin-Like Growth Factor Binding Protein-1 Promoter Activity Endocrinology, October 1, 2005; 146(10): 4274 - 4280. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhu, W. Jiang, and H. J. Thompson Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas Carcinogenesis, July 1, 2003; 24(7): 1225 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Maures and C. Duan Structure, Developmental Expression, and Physiological Regulation of Zebrafish IGF Binding Protein-1 Endocrinology, July 1, 2002; 143(7): 2722 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lang, G. J. Nystrom, and R. A. Frost Burn-induced changes in IGF-I and IGF-binding proteins are partially glucocorticoid dependent Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R207 - R215. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsukawa, Y. Inoue, Y. Oishi, H. Kato, and T. Noguchi Up-Regulation of Upstream Stimulatory Factors by Protein Malnutrition and Its Possible Role in Regulation of the IGF-Binding Protein-1 Gene Endocrinology, November 1, 2001; 142(11): 4643 - 4651. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Birt, E. Duysen, W. Wang, and A. Yaktine Corticosterone Supplementation Reduced Selective Protein Kinase C Isoform Expression in the Epidermis of Adrenalectomized Mice Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 679 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schweizer-Groyer, N. Jibard, E. Neau, D. Fortin, F. Cadepond, E.-E. Baulieu, and A. Groyer The Glucocorticoid Response Element II Is Functionally Homologous in Rat and Human Insulin-like Growth Factor-binding Protein-1 Promoters J. Biol. Chem., April 23, 1999; 274(17): 11679 - 11686. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. REAGAN, A. M. MAGARINOS, and B. S. McEWEN Neurological Changes Induced by Stress in Streptozotocin Diabetic Rats Ann. N.Y. Acad. Sci., January 1, 1999; 893(1): 126 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Levitt Katz, M. S. Satin-Smith, P. Collett-Solberg, L. Baker, C. A. Stanley, and P. Cohen Dual Regulation of Insulin-Like Growth Factor Binding Protein-1 Levels by Insulin and Cortisol during Fasting J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4426 - 4430. [Abstract] [Full Text] |
||||
![]() |
K. Higaki, Y. Matsumoto, R. Fujimoto, Y. Kurosaki, and T. Kimura Pharmacokinetics of Recombinant Human Insulin-Like Growth Factor-I in Diabetic Rats Drug Metab. Dispos., November 1, 1997; 25(11): 1324 - 1327. [Abstract] [Full Text] |
||||
![]() |
D.-S. Suh and M. M. Rechler Hepatocyte Nuclear Factor 1 and the Glucocorticoid Receptor Synergistically Activate Transcription of the Rat Insulin-like Growth Factor Binding Protein-1 Gene Mol. Endocrinol., November 1, 1997; 11(12): 1822 - 1831. [Abstract] [Full Text] |
||||
![]() |
R. M. Sapolsky and E. M. Spencer Insulin-like growth factor I is suppressed in socially subordinate male baboons Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1346 - R1351. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |